Professional Documents
Culture Documents
Ferrous Sulfate Drug Study
Ferrous Sulfate Drug Study
J. B.
Age
34 y.o
Height
53
Diagnosis
Sex
Female
Weight
60 kg
Author
M. M. Olmillo
Website
milkv.co.vu
A/N
youre welcome J
DRUG DATA
Generic name:
Ferrous sulfate
CLASSIFICATION
Pharmacologic:
Iron preparation
Trade name/s:
Femiron,
Hemocyte, Ircon
Patients dose:
1tab TID
Therapeutic:
Iron preparation
MECHANISM OF
ACTION
Maximum dose:
350mg/day
Onset:
4 days
Minimum dose:
8mg/day
Availability:
Tablets sulfate,
324, 325mg;
syrup fumarate
150mg; elixir
sulfate,
220mg/5mL,
drops sulfate,
75mg/0,6mL,
125mg/mL; tablet,
chewable
fumarate, 100mg;
suspension
fumarate,
100mg/5mL
Pregnancy Category
Risk: A
Peak:
7-10 days
INDICATIONS
General:
> prevention and
treatment of irondeficiency
anemias
> dietary
supplement for
iron
> unlabeled use:
supplemental use
during epoetin
therapy to ensure
proper
hematologic
response to
epoetin
Duration:
2-4 mo.
Metabolism:
Recycled for use, not
known
Distribution:
crosses placenta,
enters breast milk
Excretion:
unknown
Patients actual
indication:
Ferrous sulfate is
given to the
patient for the
prevention and
treatment of irondeficiency anemia
brought about by
the illness
Route: PO
Source: 2011
Lippincotts NDG
Source: 2011
Lippincotts NDG
Source: 2011
Lippincotts NDG
Source: 2011
Lippincotts NDG
CONTRAINDICATI
ON
Contraindicated with
allergy to any ingredient;
sulphite allergy;
hemochromatosis,
hemosiderosis,
haemolytic anemias
Precaution:
Use cautiously with
normal iron balance;
peptic ulcer, regional
enteritis, ulcerative colitis
ADVERSE
EFFECTS
Interactions:
> drug-drug: decreased
nti-infective response to
ciprofloxacin, norfloxacin,
ofloxacin; decreased
absorption with antacids,
cimetidine; decreased
effects of levodopa if
taken with iron;
increased serum iron
levels with
chloramphenicol
> drug-food: decreased
absorption with antacids,
eggs or milk, coffee and
tea; avoid concurrent
administration of any of
these
Source: 2011
Lippincotts NDG
NURSING
RESPONSIBILITIE
S
Before:
> check the doctors order
> assess for allergy to any ingredient,
sulfite; hemochromatosis,
hemosiderosis, haemolytic anemias
> assess for skin lesions, color;
gums, teeth (color); bowel sounds
> monitor blood studies
> confirm that client does have iron
deficiency anemia
During:
> verify patients identity
> administer the right drug in the right
dose and route at the right time
> do not crush, chew or cut tablets
and capsules
> give drug with meals (avoiding milk,
eggs, coffee, and tea)
> administer liquid preparations in
water or juice to mask the taste and
prevent staining of teeth; have patient
drink solution with a straw
> do not take this drug with antacids
nor tetracyclines unless prescribed
After:
> warn patient that stool may be dark
or green
> arrange for periodic monitoring of
Hct and Hgb levels
> keep this drug out of reach of
children (may cause fetal poisoning)
> report severe Gi upset, lethargy,
rapid respirations and constipation
> document and record.
Source: 2011
Lippincotts NDG